Related Experiment Videos
Comparative study for preoperative staging of rectal cancer
A Waizer1, S Zitron, D Ben-Baruch
1Surgery Department A, Beilinson Medical Center, Petah-Tikva, Israel.
Diseases of the Colon and Rectum
|January 1, 1989
Summary
Digital rectal exams and transrectal ultrasound are more effective for preoperative rectal cancer staging than CT scans. These methods accurately assess rectal wall invasion, aiding surgical planning for rectal cancer patients.
Area of Science:
- Oncology
- Medical Imaging
- Surgical Assessment
Background:
- Accurate preoperative staging is crucial for effective rectal cancer treatment planning.
- Various imaging modalities are used to evaluate rectal cancer extent.
- Comparing the diagnostic accuracy of these methods is essential for clinical practice.
Purpose of the Study:
- To compare the accuracy of digital rectal examination (DRE), transrectal ultrasound (TRUS), and computerized tomography (CT) in preoperative staging of rectal cancer.
- To determine the most effective imaging modality for assessing rectal wall invasion.
- To evaluate the role of each modality in the overall preoperative assessment of rectal cancer.
Main Methods:
- A comparative study involving 68 patients diagnosed with rectal cancer.
- Preoperative evaluation using digital rectal examination, CT, and TRUS.
- Comparison of preoperative staging results with final pathologic findings after surgery.
Main Results:
- Digital rectal examination achieved 82.8% accuracy in staging rectal cancer.
- Transrectal ultrasound demonstrated 76.2% accuracy in staging.
- Computerized tomography showed 65.5% accuracy for rectal wall invasion assessment.
- Both DRE and TRUS were found to be superior to CT for evaluating rectal wall invasion.
Conclusions:
- Digital rectal examination and transrectal ultrasound are highly effective for preoperative rectal cancer assessment.
- While CT plays a role, DRE and TRUS offer superior accuracy for evaluating rectal wall invasion.
- These findings support the combined use of DRE and TRUS for optimizing preoperative staging in rectal cancer patients.